Odyssey Health
LAS VEGAS, Nevada, United States · Healthcare, Health Care, Medical
Odyssey Behavioral Healthcare is a recognized provider of evidence-based behavioral health treatment for adults and adolescents dealing with complex psychiatric disorders, eating disorders, substance use disorders, and co-occurring conditions. The company offers a comprehensive range of services, including residential, inpatient, detoxification, partial hospitalization, intensive outpatient, and t
Key facts
- Headquarters
- LAS VEGAS, Nevada, United States
- Employees
- 180
- Industries
- Healthcare, Health Care, Medical
- Status
- Public (ODYY)
- Website
- odysseybehavioralhealth.com
- Company page
Recent activity at Odyssey Health
- : SEC 8-K (1.01):
- : SEC 8-K (1.01):
- : SEC 8-K (1.01):
- : SEC 8-K (1.01): On April 21, 2026, Odyssey Health, Inc. entered into a Master Technology and Sub-license Agreement with NeuRX Health, Inc., granting its subsidiary Odyssey Medical Devices, Inc. exclusive, worldwide marketing and distribution rights to the BreastCheck TM, a non-invasive test for breast abnormalities. The transaction was executed following the satisfaction of customary closing conditions and included an amendment on the same date to finalize the agreement. A press release announcing the closing was issued on April 22, 2026, highlighting the strategic significance of this deal in expanding Odyssey's product offerings in the medical technology space.
- : SEC 8-K (1.01): On January 30, 2026, Odyssey Health, Inc. entered into multiple amendments to its Convertible Promissory Notes, amending agreements that were originally dated December 21, 2021 and December 22, 2021 with two company directors and two officers. These amendments extend the maturity date of the notes to January 31, 2027. Additionally, on January 30, 2026, the Company signed Amendment No. 11 with LGH Investments, LLC, extending the maturity of that note to April 30, 2026. Furthermore, the Company entered into Amendment No. 5 with accredited investor Jonathan Lutz, also extending to January 31, 2027. An important amendment (No. 2) was executed on February 2, 2026, effective January 31, 2026, with investor Peter J. D’Arruda, again extending the maturity to January 31, 2027. These amendments collectively reinforce the Company’s financing strategy and provide additional time for repayment amidst ongoing business operations.
- : SEC 8-K (1.01):
- : SEC 8-K (1.01): On October 14, 2025, Odyssey Health, Inc. entered into a Master Technology and Sub-license Agreement with NeuRX Health, Inc., granting exclusive worldwide rights to the BreastCheck®, a non-invasive test for breast abnormalities. This agreement, managed through Odyssey's subsidiary, is subject to certain closing conditions and includes warranties, covenants, and indemnification rights for both parties. The agreement is significant for advancing the clinical application of BreastCheck® and involves various risks associated with development and commercialization timelines. The filing includes a complete text of the Agreement as Exhibit 10.1.
- : Odyssey Health, Inc. Signs Sub-Licensing Agreement for BreastCheck® Test with Worldwide Rights
- : SEC 8-K (1.01): On October 9, 2025, Odyssey Health, Inc. entered into Amendment No. 6 to the Promissory Note originally issued on December 13, 2022, with Mast Hill Fund, L.P. This amendment extends the maturity date of the note to April 30, 2026, while deleting Section 4.16 "Amortization Payments" entirely. All other terms and conditions of the note remain unchanged. This amendment is significant as it provides additional time for repayment, which may positively impact Odyssey Health's liquidity position moving forward.
- : Odyssey Health, Inc.
Odyssey Health funding history
| Date | Round | Amount |
|---|---|---|
| Jun 2022 | Seed | $1.4M |
| Mar 2021 | Venture | Undisclosed |
| Aug 2020 | Seed | $1.1M |
Leadership
- Joseph Redmond, Executive Officer, Director
- Jerome Casey, Director
- Jeffrey Conroy, Director
- John Gandolfo, Director
- Ricky Richardson, Director
- Joseph Redmond, Executive Officer, Director
- John Gandolfo, Director
- Jerome Casey, Director
- Jeffrey Conroy, Director
- Jacob VanLandingham, Director
- Joseph Redmond, Executive Officer, Director
- John Gandolfo, Director
Verified email and direct lines for Odyssey Health’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Odyssey Health in the news
Companies similar to Odyssey Health
- Evergreen Nephrology · Healthcare, Health Care, Medical
- Route 92 Medical · Healthcare, Health Care, Medical
- Blueprint · Healthcare, Health Care, Medical
- Aquestive Therapeutics, Inc. · Healthcare, Health Care, Medical
- Wellvana · Healthcare, Health Care, Medical
About Odyssey Health: questions and answers
What does Odyssey Health do?
Odyssey Behavioral Healthcare is a recognized provider of evidence-based behavioral health treatment for adults and adolescents dealing with complex psychiatric disorders, eating disorders, substance use disorders, and co-occurring conditions. The company offers a comprehensive range of services, including residential, inpatient, detoxification, partial hospitalization, intensive outpatient, and t
Where is Odyssey Health headquartered?
Odyssey Health is headquartered in LAS VEGAS, Nevada, United States.
How many employees does Odyssey Health have?
Odyssey Health has about 180 employees.
Has Odyssey Health raised funding?
Yes. Fundz has recorded 3 funding events for Odyssey Health. The most recent, Seed of $1.4M, was in Jun 2022.
What is the latest news on Odyssey Health?
On Oct 05, 2026, SEC 8-K (1.01):
Is Odyssey Health a public company?
Yes. Odyssey Health is publicly traded under the ticker ODYY.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy